Atossa Therapeutics Inc. (NASDAQ: ATOS) stock jumped 11.00% on Thursday to $0.97 against a previous-day closing price of $0.87. With 2.96 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.36 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.0200 whereas the lowest price it dropped to was $0.8700. The 52-week range on ATOS shows that it touched its highest point at $1.36 and its lowest point at $0.50 during that stretch. It currently has a 1-year price target of $4.75. Beta for the stock currently stands at 1.17.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ATOS was up-trending over the past week, with a rise of 35.46%, but this was up by 59.75% over a month. Three-month performance surged to 29.50% while six-month performance rose 24.29%. The stock gained 9.71% in the past year, while it has gained 82.72% so far this year. A look at the trailing 12-month EPS for ATOS yields -0.21 with Next year EPS estimates of -0.25. For the next quarter, that number is -0.06. This implies an EPS growth rate of -20.80% for this year and 0.00% for next year.
Float and Shares Shorts:
At present, 126.62 million ATOS shares are outstanding with a float of 126.57 million shares on hand for trading. On Apr 27, 2023, short shares totaled 8.07 million, which was 6.38% higher than short shares on Mar 30, 2023. In addition to Dr. Steven C. Quay FCAP, M.D., Ph.D. as the firm’s Chairman, CEO & Pres, Mr. Kyle Guse CPA, CPA, Esq. serves as its CFO, Gen. Counsel & Sec.
Through their ownership of 20.66% of ATOS’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 7.02% of ATOS, in contrast to 6.05% held by mutual funds. Shares owned by individuals account for 0.00%. As the largest shareholder in ATOS with 4.46% of the stake, The Vanguard Group, Inc. holds 5,651,187 shares worth 5,651,187. A second-largest stockholder of ATOS, BlackRock Fund Advisors, holds 2,609,422 shares, controlling over 2.06% of the firm’s shares. Laurion Capital Management LP is the third largest shareholder in ATOS, holding 2,225,800 shares or 1.76% stake. With a 2.99% stake in ATOS, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 3,779,376 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 1.33% of ATOS stock, is the second-largest Mutual Fund holder. It holds 1,686,157 shares valued at 1.08 million. Fidelity Extended Market Index Fu holds 0.53% of the stake in ATOS, owning 670,788 shares worth 0.43 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, ATOS reported revenue of $0.00 and operating income of -$6.59M. The EBITDA in the recently reported quarter was -$6.59M and diluted EPS was -$0.05.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ATOS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ATOS analysts setting a high price target of $5.25 and a low target of $4.00, the average target price over the next 12 months is $4.63. Based on these targets, ATOS could surge 441.24% to reach the target high and rise by 312.37% to reach the target low. Reaching the average price target will result in a growth of 377.32% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded ATOS stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.